Department of Surgery, Harvard Medical School, Center for Laryngeal Surgery and Voice Rehabilitation, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Laryngoscope. 2011 May;121(5):942-6. doi: 10.1002/lary.21811. Epub 2011 Apr 14.
OBJECTIVES/HYPOTHESIS: Early glottic cancer has been involuted by treatment with the 532 nm pulsed potassium-titanyl-phosphate (KTP) laser in initial clinical studies. Selective photoangiolysis of the sublesional circulation that allows for relative sparing of surrounding tissue is the presumed mechanism. No prior controlled animal-model study has analyzed the ability of selective coagulation of lesional microvasculature coagulation with the KTP laser to involute malignant lesions. This study tests the efficacy of photoangiolysis with the KTP laser in treating squamous cell carcinoma in an established animal model.
In vivo.
Malignant lesions were induced unilaterally in the cheek pouches of 21 hamsters by applying 9,10-dimethyl-1,2-benzanthrancene. The contralateral cheek pouch served as a control. Weekly lesion photodocumentation and pulsed KTP laser (30 W, 15 msec pulse width, 2 pulses/sec) treatments were done. The endpoint of each treatment was a uniform white-blanching of the lesion. Hamsters were sacrificed 1 week after the last treatment and cheek pouches were analyzed histologically.
Carcinoma was confirmed in 19 hamsters, and lesions that were initially <2 mm were more effectively treated than lesions that were >2 mm (P = .0004). Every lesion (10/10) that initially measured <2 mm resolved completely after laser treatment with minimal scarring noted at the treatment site based on histology. Lesions measuring between 2 and 5 mm resolved 33% of the time (2/6), and none (0/3) of the lesions >5 mm resolved after completion of the treatment period.
Pulsed KTP laser photoangiolysis can effectively involute small malignant lesions, but may be less effective at involuting larger (>2 mm) lesions.
目的/假设:在初步临床研究中,532nm 脉冲钾钛磷(KTP)激光已使早期声门癌退缩。假定的机制是对亚病变循环的选择性光血管破坏,从而允许周围组织相对保留。以前没有进行过对照动物模型研究来分析 KTP 激光选择性凝固病变微血管以使恶性病变退缩的能力。本研究测试了 KTP 激光在治疗已建立的动物模型中的鳞状细胞癌中的光血管破坏的疗效。
体内。
通过在颊囊中应用 9,10-二甲基-1,2-苯并蒽,在 21 只仓鼠的单侧颊囊中诱导恶性病变。对侧颊囊作为对照。每周进行病变光记录和脉冲 KTP 激光(30W,15msec 脉冲宽度,2 脉冲/秒)治疗。每次治疗的终点是病变均匀变白。在最后一次治疗后 1 周处死仓鼠,并对颊囊进行组织学分析。
在 19 只仓鼠中证实了癌症,最初<2mm 的病变比>2mm 的病变治疗效果更好(P=0.0004)。最初测量<2mm 的所有病变(10/10)在激光治疗后完全消退,根据组织学观察,治疗部位仅出现轻微的瘢痕。尺寸在 2 至 5mm 之间的病变有 33%(2/6)消退,而尺寸大于 5mm 的病变没有一个(0/3)消退。
脉冲 KTP 激光光血管破坏可以有效地使小的恶性病变退缩,但对于较大的病变(>2mm)可能效果较差。